======= MED18 =======
== Gene Information ==
* **Official Symbol**: MED18
* **Official Name**: mediator complex subunit 18
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=54797|54797]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9BUE0|Q9BUE0]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=MED18&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MED18|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/612384|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors.
|Med18|
|core mediator complex|
|termination of RNA polymerase II transcription|
|mediator complex|
|DNA-templated transcription, termination|
|transcription coregulator activity|
|transcription by RNA polymerase II|
|transcription, DNA-templated|
|nucleic acid-templated transcription|
|RNA biosynthetic process|
|nucleobase-containing compound biosynthetic process|
|heterocycle biosynthetic process|
|aromatic compound biosynthetic process|
|organic cyclic compound biosynthetic process|
|cellular nitrogen compound biosynthetic process|
|RNA metabolic process|
|cellular macromolecule biosynthetic process|
|macromolecule biosynthetic process|
|gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp98|BI-6727 0.04μM R03 exp98]]|1.73|
|[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|1.76|
^Gene^Correlation^
|[[:human genes:t:tada1|TADA1]]|0.464|
|[[:human genes:m:med16|MED16]]|0.449|
|[[:human genes:c:ccdc101|CCDC101]]|0.43|
|[[:human genes:m:mad2l1|MAD2L1]]|0.401|
Global Fraction of Cell Lines Where Essential: 177/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|1/1|
|bile duct|13/28|
|blood|9/28|
|bone|8/25|
|breast|11/33|
|central nervous system|8/56|
|cervix|3/4|
|colorectal|5/17|
|esophagus|2/13|
|fibroblast|0/1|
|gastric|3/15|
|kidney|4/21|
|liver|3/20|
|lung|19/75|
|lymphocyte|6/14|
|ovary|3/26|
|pancreas|8/24|
|peripheral nervous system|7/16|
|plasma cell|7/15|
|prostate|0/1|
|skin|3/24|
|soft tissue|1/7|
|thyroid|0/2|
|upper aerodigestive|5/22|
|urinary tract|4/29|
|uterus|3/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 1648
* **Expression level (log2 read counts)**: 4.31
{{:chemogenomics:nalm6 dist.png?nolink |}}